2 vials Save $47.50

Wolverine 10mg

2-component research blend

$124.99

KPV 10mg

Lyophilized research peptide

$112.49

Research bundle · 2 vials

Wolverine 10mg + KPV 10mg Research Bundle

USA Made, ≥99% Purity Per Compound

Separate retail vials: Wolverine 10mg (BPC-157 5mg + TB-500 5mg); KPV 10mg
USA manufactured in a Certified GMP California and Arizona laboratory.
≥99% purity target per compound with third-party HPLC, mass spectrometry, and batch-specific COAs

Combined retail value$237.48

Bundle saving−$47.50

$189.98 $237.48 Save $47.50

Each vial ships in its original retail format with its own batch COA

Dispatched from a US warehouse within 48 hours, tracked

Store at -20°C (Freeze) or 2–8°C (Refrigerated) protected from light

Disclaimer

For research purposes only. Not intended for human consumption, medical use, diagnosis, treatment, or prevention of disease.

Per-compound specifications

2 vials

Nothing in this bundle is co-formulated. Each vial keeps its own identity, purity target, and certificate, and is specified separately below.

Vial 01

Wolverine 10mg

Sequences

BPC-157: GEPPPGKPADDAGLV; TB-500: Ac-LKKTETQ

CAS: BPC-157: 137525-51-0; TB-500: 885340-08-9
Molecular mass: BPC-157: 1,419.5 g/mol; TB-500: 889.01 g/mol
Purity target: ≥99%
Form: Lyophilized Powder

Vial 02

KPV 10mg

Sequence

Lys-Pro-Val (KPV)

CAS: 67727-97-3
Molecular mass: 342.43 g/mol
Purity target: ≥99%
Form: Lyophilized Powder

Form: 2 Separate Lyophilized Powders
Purity target: ≥99% per compound (3rd-Party HPLC Tested)
Origin: All Included Products: Synthesized, Formulated & Packaged in CA/AZ, USA
Storage: Store at -20°C (Freeze) or 2–8°C (Refrigerated) protected from light

What is the Wolverine and KPV Research Bundle?

This bundle includes one Wolverine 10mg blend and one separate KPV 10mg vial. Wolverine contains BPC-157 5mg plus TB-500 5mg, while KPV is the compact Lys-Pro-Val tripeptide derived from the C-terminal sequence of alpha-MSH.

Together, the retail vials support controlled work across vascular, cell-migration, cytoskeletal, peptide-transport, and inflammatory-signaling models. They remain separate, and the bundle does not imply a proven clinical synergy.

How It Works

BPC-157 supports vascular and migration research: Preclinical studies examine VEGFR2/Akt/eNOS, FAK-paxillin, and nitric-oxide pathways.

TB-500 supplies an actin-related research motif: Ac-LKKTETQ is studied in cytoskeletal organization and cell-motility models.

KPV isolates a three-residue signal: Cell research examines PepT1 transport plus NF-κB, MAPK, and downstream cytokine responses.

Analytical data

One certificate per vial

Independent third-party HPLC assesses each compound against its ≥99% purity target, while mass spectrometry confirms identity. For each vial, the results are documented in one combined, batch-specific COA report.

Lot: KP-47494
Reported: 2026-05-12
Identity (LC-MS): Confirmed
Purity (HPLC-UV): 99.49%
Net content: 10.04 mg
Appearance: White lyophilized powder

Download COA

Why Source from 321 Peptides?

Domestic accountability.

All included compounds are synthesized, manufactured, and finished in Certified GMP California and Arizona laboratory facilities—never sourced from overseas or Mexico. That means direct domestic supply-chain accountability from production through fulfillment.

Verification you can inspect.

Protected in transit.

Every included product is freeze-dried to help preserve stability during storage and shipping. Rapid domestic fulfillment reduces unnecessary time and handling.

Lot history 7 released lots

Every batch released under each vial in this bundle, with the figure reported for each. Vials are shipped from current stock.

Compound	Lot	Reported	Purity	Net content	COA
Wolverine 10mg	WO-55604	2026-05-12	99.52%	10.08 mg	Pending
	WO-54450	2026-05-06	99.88%	10.06 mg	Pending
	WO-55027	2026-05-02	99.71%	10.07 mg	Pending
KPV 10mg	KP433	2026-06-01	99.30%	10.48 mg	PDF
	KP-47494	2026-05-12	99.49%	10.04 mg	Pending
	KP-46917	2026-05-02	99.83%	10.03 mg	Pending
	KP-48071	2026-04-30	99.46%	10.05 mg	Pending

Frequently Asked Questions

What comes in the Wolverine and KPV bundle?

The bundle includes Wolverine 10mg (BPC-157 5mg + TB-500 5mg); KPV 10mg. Each retail product arrives in its original lyophilized vial with batch-specific COA documentation.

What research pathways are studied with Wolverine and KPV?

Wolverine supports study of BPC-157 vascular signaling and TB-500 actin-related pathways. KPV is studied separately in peptide-transport and inflammatory-signaling models.